U SPORTS Football Athlete Not at Fault for Presence of Dexamethasone

(Ottawa, Ontario – May 1, 2019) – The Canadian Centre for Ethics in Sport (CCES) announced today that Samuel Thomassin, a U SPORTS football athlete affiliated with Université Laval, produced a urine sample, collected during in-competition doping control on November 3, 2018, that revealed the presence of dexamethasone, a prohibited glucocorticoid when administered by injection intra-muscularly.

Following a hearing held on March 19, 2019, Arbitrator Yves Fortier determined that the athlete was not at fault nor negligent for the presence of dexamethasone in his sample and that the athlete will receive no sanction in accordance with CADP Rule 10.4. The full decision and clear rationale for the determination of no fault or negligence can be found at www.crdsc-sdrcc.ca.

Although the athlete was determined to have no fault or negligence for this situation, in accordance with CADP Rule 14.3.2 the CCES is required to publicly report the outcome of this file.

About the CCES
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to making sport better by working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

-- 30 --

For further information, please contact:

Megan Cumming
Corporate Communications Manager
+1 613-521-3340 x3233
mcumming@cces.ca